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Inappropriate ICD shocks
A
patient was implanted with a
guidant single-chamber implanta-
ble cardioverter-defibrillator (ICD)
for episodes of ventricular tachycardia in
March 2005. In September, he consulted
the outpatient clinic after a shock was
delivered. The detailed circumstances,
however, remained unclear. The panel
shows a print-out of the episode as
recorded by the ICD. While the first two
beats are of sinus origin, high-frequency
discharges (10 Hz) of increasing ampli-
tude are seen before shock delivery. Note
that the tracing is compatible with an
external electromagnetic source misin-
terpreted as an episode of ventricular
fibrillation. The following day the patient
confessed that the physiotherapist he
was visiting had asked him to test
electro-acupuncture equipment consist-
ing of two metal wands plugged to a
10 Hz–0.9 V electrical generator. The
patient reported some tingling sensations
before shock delivery. This device, sold by
a German company, warns users about
its potential side effects in patients with
an ICD or pacemaker.
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but no substitute for data. In our view, only those patients
should undergo interventions of their renal arteries that are
included in a randomised, controlled, trial of ARAS such as
CORAL. Dear and colleagues have done us a service in drawing
attention to ‘‘Guideline Mayhem’’.1
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